Radiation Therapy Manufacturers FDA Public Meeting June 10, 2010 Device Improvements To Reduce the Number of Under-Doses, Over-Doses and Misaligned Exposures.

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

Quality Management Branch Cady Clark, MSN, RN Branch Manager Claudia Himes-Crayton, BSN, RN Patricia Palm, MS, RNC Nurse Consultants.
Medication Management
User Training Prabhakar Tripuraneni, MD, FACR, FASTRO Head, Radiation Oncology Scripps Clinic, La Jolla, CA.
Adapted from ISEF webpage Society for Science and the Public “Roles and Responsibilities of students and adults” Roles and Responsibilities of students.
Licensure Requirements for Cosmetic Laser Procedures By: Vickie L. Mickey, CT,CLHRP.
Nuclear and Radiation Safety Center, China Regulatory requirements on management of radioactive material safe transport in China Reporter: Xu Chunyan Division.
Health Care Careers Education Aspects. Copyright © 2004 by Thomson Delmar Learning. ALL RIGHTS RESERVED.2 Accrediting Agencies Purpose: to establish standards.
James M. Hevezi, Ph.D., FACR/FAAPM On behalf of American College of Radiology Chair, ACR Commission on Medical Physics Director of Medical Physics CyberKnife.
IAEA International Atomic Energy Agency Responsibility for Radiation Safety Day 8 – Lecture 4.
FDA-QA-DAS/2010 FDA’s Public Meeting: Device Improvements to Reduce the Number of Under-doses, Over-doses, and Misaligned Exposures from Therapeutic Radiation.
1 LASER SAFETY NSC Clinical and Operational Conference Calls August 24, 2005.
Laboratory Personnel Dr/Ehsan Moahmen Rizk.
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Quality Assurance: Manufacturer & Clinical Aspects  Alan Cohen, M.S. DABR  Paul Naine, MSc. MIPEM  Jim Schewe, PhD, DABMP Accuray Incorporated Elekta.
Regulatory Body MODIFIED Day 8 – Lecture 3.
Responsible CarE® Employee health and Safety Code David Sandidge Director, Responsible Care American Chemistry Council June 2010.
Prelim 11/14/11. 2 nd Semester, 3 rd Year Level  The Early 1900’s, With The Work Of An Industrial Engineer Named Frederick Winslow Taylor.  “Father.
Quality & Regulatory Services, Inc. | 1 USER TRAINING Presented By Robert J. Morton, M.S. Certified Radiological Physicist President Quality.
Food and Drug Administration Public Meeting June 9-10: Quality Assurance of Therapeutic Medical Devices In Radiation Oncology Nabil Adnani, Ph.D., DABR.
Unit IV Analyzing the Image. Unit IV Analyzing the Image.
 Quality & Safety Considerationsin Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy.
CLINICAL ENGINEERING part(3) Dr. Dalia H. Elkamchouchi.
Part 12. Protection of the public
FDA Public Meeting Device Improvements to Reduce the Number of Under-Doses, Over-Doses, and Misaligned Exposures From Therapeutic Radiation James M. Galvin,
Mechanical Integrity Written Procedures. Lesson Objectives  Describe Required Written Procedures for Establishing an MI Program  List Acceptable Sources.
FDA Public Meeting: Device Improvements to Reduce the Number of Under-doses and Misaligned Exposures from Therapeutic Radiation.
Prime Responsibility for Radiation Safety
Dr. Dalia H. Elkamchouchi CLINICAL ENGINEERING part(4)
CDRH INITIATIVES FOR AGING IN PLACE NIH Aging in Place Workshop September 10-11, 2014 Presented by Mary Brady, MSN, RN Senior Policy Advisor Center for.
Programme Performance Criteria. Regulatory Authority Objectives To identify criteria against which the status of each element of the regulatory programme.
QA Best Practices Tool Kit Task Force The Back Story QA Summit The Healthcare Documentation Quality Assessment and Management Best Practices Tool Kit.
Radiation Therapy Manufacturers Status of Radiation Therapy Training by Manufacturers Joint MITA - AdvaMed radiotherapy industry working group : Accuray.
SAFE/EFFECTIVE USE OF EQUIPMENT AND SUPPLIES PURPOSE To provide guidelines for the instruction of patients and family/caregivers regarding the safe,
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Technical Services.
Part VIII:Medical Exposures in Radiotherapy Lecture 2 : Scope and Responsibilities – Training of staff IAEA Post Graduate Educational Course on Radiation.
FDA Meeting June 9, 2010 “User Training” Donald A. Goer, Ph.D. Chief Scientist Intraop medical Corporation.
Diagnostic and Therapeutic Services. Learning Targets… What are the responsibilities of diagnostic and therapeutic services personnel? How is patient.
 Pharmaceutical Care is a patient-centered, outcomes oriented pharmacy practice that requires the pharmacist to work in concert with the patient and.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Program Performance Criteria.
Board Certification Mechanism Taiwan's experience Ti-Chuang Chiang Former Secretary, Chinese Society of Medical Physics, Taipei Division of Medical Informatics,
Radiopharmaceutical Production
Enhancement of Radiological Safety Culture within Ignalina NPP and Contractors Viktor PLETNIOV Ignalina Nuclear Power Plant Lithuania Gintautas KLEVINSKAS.
1.05 Effective Healthcare Teams
IS THERE A SPECIFIC PROFESSIONAL ACT FOR CLINICAL ENGINEERS? Gnahoua Zoabli, P.Eng, M.Eng., Ph.D. 10:30 am on Friday May 27 th Performance and Quality.
Planning for Succession
National Standards for Athletic Coaches
1.05 Effective Healthcare Teams
Role of the qualified expert
Lecture : Tasks and Responsibilities in the Management of Healthcare Wastes Which one do you want ? by Dr Mohammed Ali Al Zahrani.
Occupational Radiation Protection during High Exposure Operations
Clinical engineering Lecture (8).
IAEA E-learning Program
3.01 Understand Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
World Health Organization
Objective 3.01 Understanding Diagnostic and Therapeutic Services PP 1
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
Objective 3.01 Understanding Diagnostic and Therapeutic Services
1.05 Effective Healthcare Teams
Computer in Safety-Critical Systems
Hospital pharmacy.
1.05 Effective Healthcare Teams
1.05 Effective Healthcare Teams
Quality Assurance and msds indicator 9 training Department of radiology,FMU,Faisalabad DR M SAQIB MUNIR,MBBS,MASTER OF PUBLIC ADMINISTRATION,CERTIFIED.
Presentation transcript:

Radiation Therapy Manufacturers FDA Public Meeting June 10, 2010 Device Improvements To Reduce the Number of Under-Doses, Over-Doses and Misaligned Exposures From Therapeutic Radiation Quality Assurance Dominic Siewko, CHP Philips Healthcare on Behalf of MITA and AdvaMed

Radiation Therapy Manufacturers C1. Is there a model QA program that exists which is widely accepted? If so, please describe.  Several US and International Programs AAPM Task Group Reports IAEA Tec Doc Series Level of adoption varies  May be difficult to fully implement due to time & resource limitations  Professional organizations could evaluate & prioritize according to effectiveness  Any QA Program should have two aspects: 1. QA of Treatment Device & Accessories 2. QA of Patient-Specific Data & Processes

Radiation Therapy Manufacturers C2. What types of QA should be the responsibility of the facility, the physicist, the operator, others?  Clinical QA is Responsibility of the End User: Design & Execution of a QA program Apply scientific/clinical recommendations to establish type & frequency of tests  Users best know their own combination of products, processes, and workflow  AAPM Task group reports say: 1. Ultimate responsibility for the linear accelerator QA program lies with the Qualified Medical Physicist (QMP). 2. MD, dosimetrist, therapist, & administrator, as well as manufacturers, have supporting roles & responsibility

Radiation Therapy Manufacturers C3. Should manufacturers provide QA procedures to medical facilities and users of radiation therapy devices? If so, why, and what instructions should be provided? If not, why not? How extensive should they be?  Manufacturers need to provide instructions for safe use  Manufacturers may provide recommendations or references to clinical QA guidance  Manufacturers should provide education & information to assist user in defining QA program: Underlying principles of how the device operates Failure modes and safety mechanisms Recommended maintenance Technical help and expertise available  Robust operator training will allow health care providers to create a solid QA program

Radiation Therapy Manufacturers C4. Should manufacturers provide training on QA practices? If so, why, what type of training should be provided, and to which personnel? If not, why not and who should?  Manufacturers train users on the equipment specifications that should be checked to assure proper and safe operation of the equipment  Manufacturers should provide information to users on QA practices and training opportunities Peer to peer training Manufacturer training Professional Society training